Search results for "Hepatitis"


 
Results 21 - 30 of about 90 for "Hepatitis".
Sort by: Relevance | Newest | Oldest

Reformulation of extended-release oxycodone may have triggered increase in hepatitis C rates

Hepatitis C virus infections increased three times faster in states with above-median rates of initial misuse of extended-release oxycodone (OxyContin) than in states with below-median rates, and the increase began immediately after a reformulation of the drug in 2010.
https://gastroenterology.acponline.org/archives/2019/02/22/1.htm
22 Feb 2019

Review: In chronic hepatitis C virus infection, oral direct-acting antivirals have high sustained virologic response

A commentary in ACP Journal Club noted that while screening and treating all patients with chronic hepatitis C virus (HCV) would be cost-effective and probably cost-saving, some payers are still resistant.
https://gastroenterology.acponline.org/archives/2017/07/28/11.htm
28 Jul 2017

Hepatitis A infections nearly triple, with some states seeing 5-fold increase, CDC says

The increase primarily occurred among people who reported drug use or homelessness.
https://gastroenterology.acponline.org/archives/2019/05/24/2.htm
24 May 2019

Spotlight on autoimmune hepatitis

One study compared the hospitalization rate for autoimmune hepatitis among black, Latino, and Asian/Pacific Islander patients versus a reference rate among white patients, while another study retrospectively analyzed budesonide as a second-line agent in patients with autoimmune hepatitis initially treated with prednisolone.
https://gastroenterology.acponline.org/archives/2018/02/23/5.htm
23 Feb 2018

Case reports describe unusual GI conditions

Recent case reports focused on antibiotic-induced autoimmune hepatitis, cholecystitis related to Epstein-Barr virus, and linagliptin-induced pancreatitis.
https://gastroenterology.acponline.org/archives/2023/10/27/6.htm
27 Oct 2023

Lipophilic statins associated with significantly reduced hepatocellular carcinoma incidence, mortality in hepatitis

Potential benefits of lipophilic statins appeared to be dose- and duration-dependent, with the greatest reduction in hepatocellular carcinoma risk seen with use of a moderate-dose statin for about two years, according to data from a registry of Swedish patients with hepatitis B or C.
https://gastroenterology.acponline.org/archives/2019/08/23/7.htm
23 Aug 2019

Spotlight on hepatitis A, B, and C

The past month's gastroenterology research may not have been simple as ABC, but it did focus on the major types of hepatitis, including a hepatitis A outbreak, a comparison of hepatitis B drugs, and new data on hepatitis C complications and incidence.
https://gastroenterology.acponline.org/archives/2019/10/25/5.htm
25 Oct 2019

New ACIP adult immunization schedule changes flu, hepatitis A and B vaccination advice

Among other updates from the Advisory Committee on Immunization Practices, any licensed influenza vaccine that is appropriate for the age and health status of the patient may be used.
https://gastroenterology.acponline.org/archives/2019/02/22/6.htm
22 Feb 2019

ACIP updates hepatitis A vaccination recommendations

The Advisory Committee on Immunization Practices (ACIP) changed its recommendations regarding vaccination of patients with chronic liver disease, pregnant women, and those treated with blood products for clotting disorders, among other revisions.
https://gastroenterology.acponline.org/archives/2020/07/24/1.htm
24 Jul 2020

8 weeks of ledipasvir/sofosbuvir may be effective for genotype 1 hepatitis C

The therapy should be considered in patients with genotype 1 infection who are treatment-naive, do not have cirrhosis, and have a pretreatment viral load below 6,000,000 IU/mL, a study found.
https://gastroenterology.acponline.org/archives/2017/03/24/2.htm
24 Mar 2017

Result Page: Prev   1   2   3   4   5   6   7   8   9   Next